Michael Lutz

Vorstandsvorsitzender bei

Iota Sciences Ltd.

58 Jahre

7 Beziehungen

Health Technology

Consumer Services

Technology Services

Profil

Michael Lutz currently works at Iota Sciences Ltd., as Chief Executive Officer & Director from 2023, 2cureX ApS, as Director from 2020, and Noscendo GmbH, as Director.
Dr. Lutz also formerly worked at HepaRegeniX GmbH, as Chief Executive Officer & Managing Director, NTP Nano Tech Projects SRL, as Executive Chairman, Lophius Biosciences GmbH, as Managing Director, and 2cureX AB, as Independent Director from 2020 to 2023.
Dr. Lutz received his doctorate degree from Swiss Federal Institute of Technology.

Aktive Positionen von Michael Lutz

Unternehmen	Position	Beginn
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Direktor/Vorstandsmitglied	01.01.2020
Noscendo GmbH Noscendo GmbH Medical SpecialtiesHealth Technology Develops bioinformatics solutions for identifying and assess pathogens in bloodstream associated & related infections	Direktor/Vorstandsmitglied	-
Iota Sciences Ltd. Iota Sciences Ltd. Packaged SoftwareTechnology Services Develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research	Vorstandsvorsitzender	01.12.2022

Alle aktiven Positionen von Michael Lutz

Ehemalige bekannte Positionen von Michael Lutz

Unternehmen	Position	Ende
2CUREX AB	Direktor/Vorstandsmitglied	01.02.2023
NTP Nano Tech Projects SRL NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services Develops advanced optical-laser microscopy technologies and devices	Vorsitzender	-
HepaRegeniX GmbH HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases	Vorstandsvorsitzender	-
Lophius Biosciences GmbH Lophius Biosciences GmbH BiotechnologyHealth Technology Develops t-cell-based diagnostic tests and provides novel solutions for infectious diseases	Vorstandsvorsitzender	-

Sehen Sie sich die Erfahrung von Michael Lutz im Detail an

Ausbildung von Michael Lutz

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Michael Lutz im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	8
Swiss Federal Institute of Technology Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
2cureX ApS 2cureX ApS Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs and technology for the treatment of cancer	Health Technology
Lophius Biosciences GmbH Lophius Biosciences GmbH BiotechnologyHealth Technology Develops t-cell-based diagnostic tests and provides novel solutions for infectious diseases	Health Technology
HepaRegeniX GmbH HepaRegeniX GmbH BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops novel therapies for the treatment of acute and chronic liver diseases	Health Technology
Iota Sciences Ltd. Iota Sciences Ltd. Packaged SoftwareTechnology Services Develops fluid-shaping technology for life sciences and biomedicine, offering innovative solutions for ambitious research	Technology Services
NTP Nano Tech Projects SRL NTP Nano Tech Projects SRL Miscellaneous Commercial ServicesCommercial Services Develops advanced optical-laser microscopy technologies and devices	Commercial Services
2cureX AB 2cureX AB Medical SpecialtiesHealth Technology Develops and supplies in vitro diagnostic (IVD) devices	Health Technology
Noscendo GmbH Noscendo GmbH Medical SpecialtiesHealth Technology Develops bioinformatics solutions for identifying and assess pathogens in bloodstream associated & related infections	Health Technology